Combination product comprising melagatran and a factor xa inhibitor

Abstract

There is provided a combination product comprising: (A) melagatran or a pharmaceutically-acceptable derivative thereof; and (B) a Factor Xa inhibitor or a pharmaceutically-acceptable derivative thereof, wherein each components (A) and (B) is formulated in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier, as well as the use of such a combination product in the treatment of a condition where anticoagulant therapy is indicated.

Dependencies are inferred from the claim text.